Forget GLP-1 Stocks, Baldness Drugs Are Wall Street's Next Goldmine
A new generation of hair loss treatments could hit the market by 2027, drawing investor interest in a multi-billion-dollar opportunity.
Aug 30, 20263 views
Pharmaceuticals
Oral GLP-1 Pill Delivers 12% Weight Loss in 36 Weeks, Could Replace Injections
New once-daily aleniglipron shows promising Phase II results, while Medicare expands coverage for existing GLP-1 drugs starting July 1.
Aug 10, 20262 views
AstraZeneca–Bristol Myers $400B Merger Talks Rock Pharma—and Fizzle Out
Reports of a record-breaking pharma tie-up sent shares tumbling before a senior source denied the talks, exposing investor skepticism and strategic tensions.
Aug 5, 20261 views
Novo's Wegovy Pill Reaches 1 Million Patients, but Competitive Heat Weighs on Shares
As Eli Lilly surges and Amazon Pharmacy enters the fray, Novo Nordisk fights back with global expansion and deep cost cuts.
Aug 5, 20262 views
Merck Paves Way for Affordable HIV Prevention Pill in Low-Income Countries
Generic versions of a new daily pill could cost as low as $5 per person per year, but access in Latin America remains uncertain.
Jul 26, 20263 views
PreviousPage 2